Published in Am J Med on May 01, 1999
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med (2008) 13.72
Frailty in elderly people. Lancet (2013) 7.40
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35
Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A (2003) 5.26
Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med (2008) 4.34
The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet (2006) 3.93
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest (2013) 3.47
Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34
Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci (2006) 2.85
Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect (2005) 2.57
Inflammatory markers in population studies of aging. Ageing Res Rev (2010) 2.57
Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985) (2006) 2.50
Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest (2007) 2.36
Air pollution and inflammation (interleukin-6, C-reactive protein, fibrinogen) in myocardial infarction survivors. Environ Health Perspect (2007) 2.24
Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci (2010) 2.24
Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr (2011) 2.21
Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am J Epidemiol (2010) 2.19
Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One (2011) 2.08
Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol A Biol Sci Med Sci (2009) 2.03
Residual immune dysregulation syndrome in treated HIV infection. Adv Immunol (2013) 2.01
Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing (2005) 1.99
Combinations of biomarkers predictive of later life mortality. Proc Natl Acad Sci U S A (2006) 1.95
Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates. Blood (2012) 1.91
Genome-wide association with select biomarker traits in the Framingham Heart Study. BMC Med Genet (2007) 1.90
Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell (2008) 1.89
Mindfulness-Based Stress Reduction training reduces loneliness and pro-inflammatory gene expression in older adults: a small randomized controlled trial. Brain Behav Immun (2012) 1.86
Social relationships, sleep quality, and interleukin-6 in aging women. Proc Natl Acad Sci U S A (2005) 1.84
Cumulative inflammatory load is associated with short leukocyte telomere length in the Health, Aging and Body Composition Study. PLoS One (2011) 1.78
High neuroticism and low conscientiousness are associated with interleukin-6. Psychol Med (2009) 1.71
Personality and longevity: knowns, unknowns, and implications for public health and personalized medicine. J Aging Res (2011) 1.68
Comorbidity, hospitalization, and mortality in COPD: results from a longitudinal study. Lung (2010) 1.65
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc Natl Acad Sci U S A (2008) 1.65
Ageing, tumour necrosis factor-alpha (TNF-alpha) and atherosclerosis. Clin Exp Immunol (2000) 1.61
Long-term physical activity and inflammatory biomarkers in older adults. Med Sci Sports Exerc (2010) 1.59
Stress, age, and immune function: toward a lifespan approach. J Behav Med (2006) 1.56
Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol (2008) 1.56
Exercise training and plasma C-reactive protein and interleukin-6 in elderly people. J Am Geriatr Soc (2008) 1.55
Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J Physiol (2009) 1.54
Positive affect and inflammation during radiation treatment for breast and prostate cancer. Brain Behav Immun (2009) 1.54
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events? PLoS Med (2009) 1.54
Total and cause-specific mortality in the cardiovascular health study. J Gerontol A Biol Sci Med Sci (2009) 1.53
Preliminary evidence for subdimensions of geriatric frailty: the MacArthur study of successful aging. J Am Geriatr Soc (2008) 1.52
Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation (2008) 1.51
Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol (2003) 1.50
Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One (2016) 1.48
Self-rated health among pregnant women: associations with objective health indicators, psychological functioning, and serum inflammatory markers. Ann Behav Med (2013) 1.48
Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study. AIDS (2010) 1.46
High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection. J Infect Dis (2010) 1.46
Long-term assessment of inflammation and healthy aging in late life: the Cardiovascular Health Study All Stars. J Gerontol A Biol Sci Med Sci (2012) 1.45
Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey. Psychosom Med (2010) 1.39
The Impact of Educational Attainment on Observed Race/Ethnic Disparities in Inflammatory Risk in the 2001-2008 National Health and Nutrition Examination Survey. Int J Environ Res Public Health (2015) 1.39
Ageing and vascular ageing. Postgrad Med J (2006) 1.36
Three-year change in inflammatory markers in elderly people and mortality: the Invecchiare in Chianti study. J Am Geriatr Soc (2007) 1.35
Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med (2013) 1.35
Sex differences in age trajectories of physiological dysregulation: inflammation, metabolic syndrome, and allostatic load. J Gerontol A Biol Sci Med Sci (2011) 1.31
Age-related changes in immune function: effect on airway inflammation. J Allergy Clin Immunol (2010) 1.29
Social-evaluative threat and proinflammatory cytokine regulation: an experimental laboratory investigation. Psychol Sci (2009) 1.28
Poorer self-rated health is associated with elevated inflammatory markers among older adults. Psychoneuroendocrinology (2011) 1.25
Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation (2010) 1.23
The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med (2008) 1.21
Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals. J Am Geriatr Soc (2011) 1.20
Gender, race/ethnicity, personality, and interleukin-6 in urban primary care patients. Brain Behav Immun (2008) 1.19
Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis (2008) 1.18
IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum Genet (2007) 1.18
Translating advances from the basic biology of aging into clinical application. Exp Gerontol (2012) 1.16
Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals. J Aging Res (2012) 1.16
Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers - a meta-analysis. J Inflamm (Lond) (2013) 1.15
Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study. PLoS One (2012) 1.14
Population differences in proinflammatory biology: Japanese have healthier profiles than Americans. Brain Behav Immun (2010) 1.14
Interleukin-6 and rheumatic diseases. Arthritis Res Ther (2006) 1.14
Elevated postoperative inflammatory biomarkers are associated with short- and medium-term cognitive dysfunction after coronary artery surgery. J Anesth (2011) 1.13
Sleep duration, cardiovascular disease, and proinflammatory biomarkers. Nat Sci Sleep (2013) 1.13
Negative emotions predict elevated interleukin-6 in the United States but not in Japan. Brain Behav Immun (2013) 1.13
C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. Cancer Causes Control (2009) 1.13
Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol (2013) 1.12
A molecular mechanism for TNF-α-mediated downregulation of B cell responses. J Immunol (2011) 1.10
Mechanisms involved in the aging-induced vascular dysfunction. Front Physiol (2012) 1.09
Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010. Curr Opin HIV AIDS (2010) 1.09
Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response. Proc Natl Acad Sci U S A (2005) 1.09
Measuring systemic inflammatory regulation in older adults: evidence and utility. Rejuvenation Res (2009) 1.09
Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. J Gerontol A Biol Sci Med Sci (2011) 1.09
Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof. Cardiovasc Diabetol (2003) 1.09
Big 5 personality traits and interleukin-6: evidence for "healthy Neuroticism" in a US population sample. Brain Behav Immun (2012) 1.08
Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study. Circ Heart Fail (2008) 1.08
Frailty and its potential relevance to cardiovascular care. Mayo Clin Proc (2008) 1.08
The link between osteoporosis and cardiovascular disease. Clin Cases Miner Bone Metab (2008) 1.08
(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. Arthritis Res Ther (2011) 1.07
Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med (2010) 1.07
Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica (2014) 1.07
Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest (2008) 1.06
Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol (2013) 1.05
Inflammatory markers and the risk of hip fracture: the Women's Health Initiative. J Bone Miner Res (2012) 1.05
High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Neurology (2009) 1.05
Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction. Exp Gerontol (2008) 1.05
Inflammation and immune system alterations in frailty. Clin Geriatr Med (2011) 1.04
Inflammation and mortality in a frail mouse model. Age (Dordr) (2011) 1.03
JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci U S A (2015) 1.03
Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2011) 1.02
Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology. Depress Anxiety (2013) 1.02
Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? Nutr Metab (Lond) (2007) 1.02
A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol (1994) 30.72
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med (1995) 20.53
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci (2000) 15.54
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Calcium-channel blockade and incidence of cancer in aged populations. Lancet (1996) 8.04
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem (1995) 7.73
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell (1988) 7.50
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37
Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol (1986) 6.88
Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med (1997) 6.72
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol (2000) 5.59
Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell (1987) 5.57
Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc (1999) 4.84
Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem (1997) 4.77
Do calcium channel blockers increase the risk of cancer? Am J Hypertens (1996) 4.75
Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol (1990) 4.63
HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA (2000) 4.62
A method for assessing drug therapy appropriateness. J Clin Epidemiol (1992) 4.36
Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst (1998) 4.27
Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol (2000) 4.16
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet (1999) 4.07
Depressive symptoms and physical decline in community-dwelling older persons. JAMA (1998) 4.05
Measuring higher level physical function in well-functioning older adults: expanding familiar approaches in the Health ABC study. J Gerontol A Biol Sci Med Sci (2001) 4.01
An unusual solitary lesion of secondary syphilis. Arch Dermatol (1967) 3.95
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood (2001) 3.93
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol (1996) 3.82
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst (2000) 3.81
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica (1997) 3.67
Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet (1998) 3.61
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet (1998) 3.61
A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med (1996) 3.53
Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons: MacArthur studies of successful aging. J Gerontol A Biol Sci Med Sci (2000) 3.45
Respiratory syncytial viral infection in children with compromised immune function. N Engl J Med (1986) 3.43
The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord (2001) 3.39
Exploring the effect of depression on physical disability: longitudinal evidence from the established populations for epidemiologic studies of the elderly. Am J Public Health (1999) 3.17
Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst (1999) 2.98
Limitations of the case-only design for identifying gene-environment interactions. Am J Epidemiol (2001) 2.97
Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA (1997) 2.92
Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB. Neurology (2010) 2.92
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev (2001) 2.87
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation (1998) 2.83
Knee osteoarthritis and physical functioning: evidence from the NHANES I Epidemiologic Followup Study. J Rheumatol (1991) 2.83
Lower extremity performance in nondisabled older persons as a predictor of subsequent hospitalization. J Gerontol A Biol Sci Med Sci (2000) 2.81
On the importance of helping families: policy implications from a national study. Ment Retard (1993) 2.71
The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med (1984) 2.70
Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol (2001) 2.68
Instruments for screening for depression and dementia in a long-term care facility. J Am Geriatr Soc (1989) 2.68
Superoxide generation by digitonin-stimulated guinea pig granulocytes. A basis for a continuous assay for monitoring superoxide production and for the study of the activation of the generating system. J Clin Invest (1978) 2.66
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol (2011) 2.54
Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc (1995) 2.51
Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections. N Engl J Med (1982) 2.47
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes (2001) 2.47
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis (2001) 2.40
Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst (1999) 2.40
Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem (1999) 2.35
Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing (1999) 2.34
Association between childhood acute lymphoblastic leukemia and use of electrical appliances during pregnancy and childhood. Epidemiology (1998) 2.33
Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc (1996) 2.32
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet (1998) 2.32
Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc (1999) 2.31
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31
Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation (2001) 2.29
Is self-rated health comparable across cultures and genders? J Gerontol B Psychol Sci Soc Sci (1998) 2.28
Functional changes in human leukemic cell line HL-60. A model for myeloid differentiation. J Cell Biol (1979) 2.28
Risk factors for falling in home-dwelling older women with stroke: the Women's Health and Aging Study. Stroke (2003) 2.28
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis (2000) 2.24
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum (1999) 2.21
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res (1990) 2.21
Inflammation in cardiovascular disease: cart, horse, or both? Circulation (1998) 2.18
Depression in elderly hospitalized patients with medical illness. Arch Intern Med (1988) 2.18
Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE) J Am Geriatr Soc (1996) 2.17
Smoking, physical activity, and active life expectancy. Am J Epidemiol (1999) 2.16
Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (1999) 2.15
Non-differential misclassification and bias towards the null: a clarification. Occup Environ Med (1995) 2.15
Hepatic sulfite oxidase. A functional role for molybdenum. J Biol Chem (1971) 2.13
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 2.11
Do men and women follow different trajectories to reach extreme longevity? Italian Multicenter Study on Centenarians (IMUSCE). Aging (Milano) (2000) 2.09
A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol (1994) 2.05
Apolipoprotein E and cognitive change in an elderly population. Ann Neurol (1996) 2.05
The association of knee injury and obesity with unilateral and bilateral osteoarthritis of the knee. Am J Epidemiol (1989) 2.04
The value of serum albumin and high-density lipoprotein cholesterol in defining mortality risk in older persons with low serum cholesterol. J Am Geriatr Soc (2001) 2.04
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet (1999) 2.03
Letter: Colonial morphology of Neisseria gonorrhoeae. JAMA (1974) 2.00
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). Leukemia (2009) 1.99
Meta-analysis of genome-wide association studies for personality. Mol Psychiatry (2010) 1.96
Foot pain and disability in older persons: an epidemiologic survey. J Am Geriatr Soc (1995) 1.95